Volume 25, Issue 1 e12723
ORIGINAL ARTICLE

Glutamatergic neurons in the medial prefrontal cortex mediate the formation and retrieval of cocaine‐associated memories in mice

Tong Zhang

Laboratory of Molecular Pharmacology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan

Search for more papers by this author
Junko Yanagida

Laboratory of Molecular Pharmacology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan

Search for more papers by this author
Hironori Kamii

Laboratory of Molecular Pharmacology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan

Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan

Search for more papers by this author
Shintaro Wada

Laboratory of Molecular Pharmacology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan

Search for more papers by this author
Masaki Domoto

Laboratory of Molecular Pharmacology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan

Search for more papers by this author
Hitoki Sasase

Laboratory of Molecular Pharmacology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan

Search for more papers by this author
Satoshi Deyama

Laboratory of Molecular Pharmacology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan

Search for more papers by this author
Takeshi Takarada

Laboratory of Molecular Pharmacology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan

Department of Regenerative Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

Search for more papers by this author
Eiichi Hinoi

Laboratory of Molecular Pharmacology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan

Search for more papers by this author
Kenji Sakimura

Department of Cellular Neurobiology, Brain Research Institute, Niigata University, Niigata, Japan

Search for more papers by this author
Akihiro Yamanaka

Department of Neuroscience II, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan

Search for more papers by this author
Takashi Maejima

Department of Integrative Neurophysiology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan

Search for more papers by this author
Michihiro Mieda

Department of Integrative Neurophysiology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan

Search for more papers by this author
Takeshi Sakurai

Department of Integrative Neurophysiology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan

International Institute for Integrative Sleep Medicine, University of Tsukuba, Tsukuba, Japan

Search for more papers by this author
Naoya Nishitani

Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan

Search for more papers by this author
Kazuki Nagayasu

Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan

Search for more papers by this author
Shuji Kaneko

Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan

Search for more papers by this author
Masabumi Minami

Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan

Search for more papers by this author
Katsuyuki Kaneda

Corresponding Author

Laboratory of Molecular Pharmacology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan

Correspondence

Katsuyuki Kaneda, Laboratory of Molecular Pharmacology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa 920‐1192, Japan.

Email: k‐kaneda@p.kanazawa‐u.ac.jp

Search for more papers by this author
First published: 07 February 2019
Citations: 8
Tong Zhang, Junko Yanagida, and Hironori Kamii equally contributed to this work.

Abstract

In drug addiction, environmental stimuli previously associated with cocaine use readily elicit cocaine‐associated memories, which persist long after abstinence and trigger cocaine craving and consumption. Although previous studies suggest that the medial prefrontal cortex (mPFC) is involved in the expression of cocaine‐addictive behaviors, it remains unclear whether excitatory and inhibitory neurons in the mPFC are causally related to the formation and retrieval of cocaine‐associated memories. To address this issue, we used the designer receptors exclusively activated by designer drugs (DREADD) technology combined with a cocaine‐induced conditioned place preference (CPP) paradigm. We suppressed mPFC neuronal activity in a cell‐type– and timing‐dependent manner. C57BL/6J wild‐type mice received bilateral intra‐mPFC infusion of an adeno‐associated virus (AAV) expressing inhibitory DREADD (hM4Di) under the control of CaMKII promotor to selectively suppress mPFC pyramidal neurons. GAD67‐Cre mice received bilateral intra‐mPFC infusion of a Cre‐dependent AAV expressing hM4Di to specifically silence GABAergic neurons. Chemogenetic suppression of mPFC pyramidal neurons significantly attenuated both the acquisition and expression of cocaine CPP, while suppression of mPFC GABAergic neurons affected neither the acquisition nor expression of cocaine CPP. Moreover, chemogenetic inhibition of mPFC glutamatergic neurons did not affect the acquisition and expression of lithium chloride‐induced conditioned place aversion. These results suggest that the activation of glutamatergic, but not GABAergic, neurons in the mPFC mediates both the formation and retrieval of cocaine‐associated memories.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.